The predictive role of thrombocytosis in benign, borderline and malignant ovarian tumors
Ovarian cancer is a lethal gynecological malignancy. Although CA-125 is commonly measured in women with adnexal mass, it is estimated that it only has a positive predictive value (PPV) of 69% and a negative predictive value (NPV) of 88% for the detection of ovarian cancer. The aim of this study was...
Main Authors: | Ganiy Opeyemi Abdulrahman, Nagindra Das, K Lutchman Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-08-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2019.1686755 |
Similar Items
-
Pelvic mass, ascites, hydrothorax: a malignant or benign condition?
Meigs syndrome with high levels of CA 125
by: Guglielmo Stabile, et al.
Published: (2021-05-01) -
The significance of preoperative thrombocytosis in ovarian cancer patients
by: Irina Balescu, et al.
Published: (2022-12-01) -
Significance of preoperative thrombocytosis in epithelial ovarian cancer
by: Crasta Julian, et al.
Published: (2010-01-01) -
Platelets, Thrombocytosis, and Ovarian Cancer Prognosis: Surveying the Landscape of the Literature
by: Demetra H. Hufnagel, et al.
Published: (2020-10-01) -
Thrombocytosis and CA125 as Predictor of Malignancy in Gynaecological Pelvic Mass
by: Najmah M. Miran
Published: (2018-10-01)